Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulators of urinary stone formation.

Saeed R Khan1, Dirk J Kok

  • 1Department of Pathology, University of Florida, Gainesville, Florida, USA. khan@pathology.ufl.edu

Frontiers in Bioscience : a Journal and Virtual Library
|February 24, 2004
PubMed
Summary

Urine contains molecules that control kidney stone formation by inhibiting crystal growth and aggregation. These compounds, including proteins and glycosaminoglycans, are crucial for preventing calcium oxalate stones and maintaining kidney health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apoptosis, ferroptosis, necrosis, necroptosis and pyroptosis in the formation of calcium oxalate kidney stones.

Urolithiasis·2025
Same author

Oxidative stress, inflammation and kidney stones.

Urolithiasis·2025
Same author

Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence.

Asian journal of urology·2023
Same author

Editorial: Immunity and Inflammatory Response in Kidney Stone Disease.

Frontiers in immunology·2021
Same author

Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Nature reviews. Nephrology·2021
Same author

Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.

Urolithiasis·2021

Area of Science:

  • Urology
  • Nephrology
  • Biochemistry

Background:

  • Urine contains compounds that regulate crystal formation and attachment to renal cells.
  • These modulators protect kidneys from crystallization, crystal retention, and plaque formation.
  • Calcium oxalate (CaOx) is the most common kidney stone type, making its modulation critical.

Purpose of the Study:

  • To examine the effects of various urinary compounds on calcium oxalate crystallization.
  • To identify key macromolecules involved in inhibiting or promoting CaOx crystal formation.
  • To explore the relationship between crystallization modulators, inflammation, and kidney stone disease (nephrolithiasis).

Main Methods:

  • Analysis of crystallization modulators in urine, focusing on macromolecules.

Related Experiment Videos

  • Identification of inhibitory macromolecules like glycoproteins and glycosaminoglycans.
  • Investigation of nucleation promotion by membrane lipids.

    • Main Results:

    • Macromolecules, including specific proteins (Nephrocalcin, THP, Osteopontin, Urofragment 1, Bikunin) and glycosaminoglycans (CS, HS, HA), exhibit significant inhibitory activity against CaOx crystallization.
    • Membrane lipids are implicated in promoting nucleation.
    • Renal epithelial cells and macrophages are involved in inflammatory responses to oxalate and CaOx crystals, suggesting a link between inflammation and stone formation.

    Conclusions:

    • Urinary macromolecules play a vital role in preventing kidney stone formation by inhibiting calcium oxalate crystallization.
    • The study highlights the dual role of some molecules in both crystal modulation and inflammatory processes.
    • A strong association exists between inflammation and the pathogenesis of nephrolithiasis.